Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 14.6.2021 | EN | Official Journal of the European Union | C 228/13 |

---

Appeal brought on 26 January 2021 by Allergan Holdings France against the judgment of the General Court (Third Chamber) delivered on 18 November 2020 in Case T-664/19, Allergan Holdings France v EUIPO — Dermavita (JUVEDERM ULTRA)

(Case C-41/21 P)

(2021/C 228/17)

Language of the case: English

Parties

Appellant: Allergan Holdings France (represented by: T. de Haan, avocat, and J. Day, Solicitor)

Other parties to the proceedings: European Union Intellectual Property Office (EUIPO), Dermavita Co. Ltd

By order of 29 April 2021, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that Allergan Holdings France should bear its own costs.

---

[Top](#document1)